Literature DB >> 29573311

Secular trends in opportunistic infections, cancers and mortality in patients with AIDS during the era of modern combination antiretroviral therapy.

E Sezgin1,2, M L Van Natta2, J E Thorne2,3, M A Puhan2,4, D A Jabs2,5,6.   

Abstract

OBJECTIVES: The aim of the study was to estimate the incidence of, determine risk factors for, and investigate the consequences of opportunistic infections (OIs) and malignancies among patients with the acquired immune deficiency syndrome (AIDS) in the era of modern combination antiretroviral therapy (cART).
METHODS: Three enrolment periods (1998-2002, 2003-2005 and 2006-2012), corresponding to changes in predominant cART regimens, were compared among 1889 participants enrolled in a prospective cohort study, the Longitudinal Study of Ocular Complications of AIDS (LSOCA). Incidences of AIDS-related OIs and cancers were estimated. Multivariate logistic and Cox regression models were used to determine the effect of demographic and clinical characteristics on OIs and mortality.
RESULTS: Between participants enrolled in the 1998-2002 and 2006-2012 enrolment periods, the incidence of OIs decreased from 27 per 1000 person-years (PY) to 11 per 1000 PY (P < 0.001), and mortality decreased from 41 per 1000 PY to 18 per 1000 PY (P < 0.0001), corresponding to improvements in cART regimens.
CONCLUSIONS: Improvements in cART regimens led to a progressive decline in the incidence of OIs and mortality between 1999 and 2013 among patients with AIDS in the era of modern cART.
© 2018 British HIV Association.

Entities:  

Keywords:  AIDS; AIDS-related cancer; HIV; mortality; opportunistic infection

Mesh:

Year:  2018        PMID: 29573311      PMCID: PMC7063834          DOI: 10.1111/hiv.12609

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  43 in total

1.  Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons. Adult/Adolescent Spectrum of HIV Disease Project Group.

Authors:  J L Jones; D L Hanson; M S Dworkin; J W Ward; H W Jaffe
Journal:  J Acquir Immune Defic Syndr       Date:  1999-08-01       Impact factor: 3.731

2.  Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease.

Authors:  E L Murphy; A C Collier; L A Kalish; S F Assmann; M F Para; T P Flanigan; P N Kumar; L Mintz; F R Wallach; G J Nemo
Journal:  Ann Intern Med       Date:  2001-07-03       Impact factor: 25.391

3.  Opportunistic infections as causes of death in HIV-infected patients in the HAART era in France.

Authors:  Fabrice Bonnet; Charlotte Lewden; Thierry May; Laurence Heripret; Eric Jougla; Sibylle Bevilacqua; Dominique Costagliola; Dominique Salmon; Geneviève Chêne; Philippe Morlat
Journal:  Scand J Infect Dis       Date:  2005

4.  Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment.

Authors:  Douglas A Jabs; Mark L Van Natta; Janet T Holbrook; John H Kempen; Curtis L Meinert; Matthew D Davis
Journal:  Ophthalmology       Date:  2007-01-08       Impact factor: 12.079

5.  Hospitalizations for metabolic conditions, opportunistic infections, and injection drug use among HIV patients: trends between 1996 and 2000 in 12 states.

Authors:  Kelly A Gebo; John A Fleishman; Richard D Moore
Journal:  J Acquir Immune Defic Syndr       Date:  2005-12-15       Impact factor: 3.731

6.  AIDS across Europe, 1994-98: the EuroSIDA study.

Authors:  A Mocroft; C Katlama; A M Johnson; C Pradier; F Antunes; F Mulcahy; A Chiesi; A N Phillips; O Kirk; J D Lundgren
Journal:  Lancet       Date:  2000-07-22       Impact factor: 79.321

7.  Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America.

Authors:  Jonathan E Kaplan; Constance Benson; King K Holmes; John T Brooks; Alice Pau; Henry Masur
Journal:  MMWR Recomm Rep       Date:  2009-04-10

8.  Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994-2005.

Authors:  Kate Buchacz; Rose K Baker; Anne C Moorman; James T Richardson; Kathleen C Wood; Scott D Holmberg; John T Brooks
Journal:  AIDS       Date:  2008-07-11       Impact factor: 4.177

9.  Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals.

Authors:  Jessica L Long; Eric A Engels; Richard D Moore; Kelly A Gebo
Journal:  AIDS       Date:  2008-02-19       Impact factor: 4.177

10.  Changes in causes of death among adults infected by HIV between 2000 and 2005: The "Mortalité 2000 and 2005" surveys (ANRS EN19 and Mortavic).

Authors:  Charlotte Lewden; Thierry May; Eric Rosenthal; Christine Burty; Fabrice Bonnet; Dominique Costagliola; Eric Jougla; Caroline Semaille; Philippe Morlat; Dominique Salmon; Patrice Cacoub; Geneviève Chêne
Journal:  J Acquir Immune Defic Syndr       Date:  2008-08-15       Impact factor: 3.731

View more
  7 in total

1.  Simple Identification of Mycobacterial Species by Sequence-Specific Multiple Polymerase Chain Reactions.

Authors:  Nihan Unubol; Inci Tuney Kizilkaya; Sinem Oktem Okullu; Kaya Koksalan; Tanil Kocagoz
Journal:  Curr Microbiol       Date:  2019-05-09       Impact factor: 2.188

2.  Characteristics and Clinical Course of Alveolar Echinococcosis in Patients with Immunosuppression-Associated Conditions: A Retrospective Cohort Study.

Authors:  Ansgar Deibel; Cordula Meyer Zu Schwabedissen; Lars Husmann; Felix Grimm; Peter Deplazes; Cäcilia S Reiner; Beat Müllhaupt
Journal:  Pathogens       Date:  2022-04-06

Review 3.  Host Genetics of Cytomegalovirus Pathogenesis.

Authors:  Efe Sezgin; Ping An; Cheryl A Winkler
Journal:  Front Genet       Date:  2019-07-23       Impact factor: 4.599

4.  Antiretroviral Long-Term Efficacy and Resistance of Lopinavir/Ritonavir Plus Lamivudine in HIV-1-Infected Treatment-Naïve Patients (ALTERLL): 144-Week Results of a Randomized, Open-Label, Non-Inferiority Study From Guangdong, China.

Authors:  Peng-Le Guo; Hao-Lan He; Xie-Jie Chen; Jin-Feng Chen; Xiao-Ting Chen; Yun Lan; Jian Wang; Pei-Shan Du; Huo-Lin Zhong; Hong Li; Cong Liu; Li-Ya Li; Feng-Yu Hu; Xiao-Ping Tang; Wei-Ping Cai; Ling-Hua Li
Journal:  Front Pharmacol       Date:  2021-03-25       Impact factor: 5.810

5.  Examining 5-Year Cervical Cytology Progression Among Minority Women Living With HIV and Baseline Negative Cytology.

Authors:  Alex P Sanchez-Covarrubias; Joshua Crane; Emily K Montgomerie; JoNell E Potter; Lunthita M Duthely; Felicia Bahadue; Patricia P Jeudin
Journal:  J Low Genit Tract Dis       Date:  2022-10-01       Impact factor: 3.842

Review 6.  Treatment and Prevention of Histoplasmosis in Adults Living with HIV.

Authors:  David S McKinsey
Journal:  J Fungi (Basel)       Date:  2021-05-28

7.  Different Trends of Distinct Time Points of AIDS Events Following HIV Diagnosis in Various At-risk Populations: A Retrospective Nationwide Cohort Study in Taiwan.

Authors:  Chun-Yuan Lee; Pei-Hua Wu; Po-Liang Lu; Fu-Wen Liang
Journal:  Infect Dis Ther       Date:  2021-07-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.